Maastricht University Hospital
Maastricht, Limburg, 6229HX, Netherlands
NCT Number: NCT00519350
Patients undergoing major surgery, trauma or burns are prone to develop an exacerbated inflammatory response, which is potentially lethal to the individual. Recently, the researchers' group showed in a rodent model of hemorrhagic shock that high-fat feeding administered before shock attenuates inflammation and reduces intestinal and hepatic damage. In the mechanism that underlies this protective effect, the release of cholecystokinin in gut wall and activation of efferent vagus bundles are crucial events. Before investigating the effect of high-fat nutrition in clinical setting, suitable markers of inflammation and organ damage need to be selected. In this study, blood will be collected in patients undergoing different types of operations. Consequently several markers for inflammation and organ damage will be determined. Hence, suitable parameters for a future high-fat intervention study will be selected.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Maastricht, Limburg, 6229HX, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In arterial or venous lines already present, small amounts of blood will be collected at certain timepoints following operation
Maastricht University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05469048
Infections, Inflammation
Los Angeles, California, United States
View Trial DetailsNCT05213923
Infections, Inflammation
Lebanon, New Hampshire, United States
View Trial DetailsNCT03604731
Infections, Inflammation
View Trial DetailsNCT02852902
Bacteremia, Bacterial Infections
Córdoba, Spain
View Trial Details